SBC SBC Medical Group Holdings Inc

Nasdaq sbc-holdings.com


$ 3.65 $ -0.05 (-1.35 %)    

Tuesday, 28-Oct-2025 15:59:54 EDT
QQQ $ 633.55 $ 4.83 (0.77 %)
DIA $ 476.83 $ 1.80 (0.38 %)
SPY $ 687.33 $ 1.82 (0.27 %)
TLT $ 92.10 $ 0.24 (0.26 %)
GLD $ 364.95 $ -2.63 (-0.72 %)
$ 3.66
$ 3.72
$ 3.50 x 4
$ 4.19 x 100
$ 3.65 - $ 3.73
$ 2.62 - $ 7.99
35,305
na
380.21M
$ 0.64
$ 11.41
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-13-2025 06-30-2025 10-Q
2 05-15-2025 03-31-2025 10-Q
3 03-28-2025 12-31-2024 10-K
4 11-13-2024 09-30-2024 10-Q
5 08-16-2024 06-30-2024 10-Q
6 05-20-2024 03-31-2024 10-Q
7 03-19-2024 12-31-2023 10-K
8 11-14-2023 09-30-2023 10-Q
9 08-14-2023 06-30-2023 10-Q
10 05-15-2023 03-31-2023 10-Q
11 03-09-2023 12-31-2022 10-K
12 11-14-2022 09-30-2022 10-Q
13 09-09-2022 06-30-2022 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

SBC Medical Group Holding (NASDAQ:SBC) reported quarterly earnings of $0.02 per share which missed the analyst consensus estima...

Core News & Articles

SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical" or the "Company"), a global franchise and p...

Core News & Articles

SBC Medical Group Holdings (Headquarters: California, USA; CEO: Yoshiyuki Aikawa) hereby announces that, based on the announcem...

Core News & Articles

SBC Medical Group Holding (NASDAQ:SBC) reported quarterly earnings of $0.06 per share. The company reported $44.00 million in ...

Core News & Articles

MEDIROM Healthcare Technologies Inc. (NASDAQ:MRM) announced a business alliance with SBC Medical Group Holdings Incorporated (N...

 miracle-weight-loss-drug-ozempic-and-similar-drugs-reduce-alcohol-and-opioid-overdose-study-reveals

Research published in the journal Addiction indicates that GLP-1 drugs like Ozempic may play a crucial role in reducing substan...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION